Table 2.

Average monthly costs of medical therapy ^† (€)

	Drug	Administration (i.v.)	Biochemical tests	Follow‐up visits	Total
Gefitinib	2.190	0	20	14	2.224
Afatinib	1.796	0	20	14	1.830
Erlotinib	1.864	0	20	14	1.898
Crizotinib	4.154	0	20	14	4.188
Pemetrexed + cisplatin	2.914	480	0	0	3.394
Bevacizumab	4604	480	0	0	5.007
Pembrolizumab	5.938	480	0	0	6.418
Nivolumab	4.215	755	0	0	4.970
Nintedanib + docetaxel	643	480	0	0	1.123
Osimertinib	5.437	0	20	14	5.471
Alectinib (I line)	5.208	0	20	14	5.240
Alectinib (II line)	3.958	0	20	14	3.990
Atezolizumab	4.395	480	0	0	4.875
Ceritinib	2.035	0	12	9	2.055

^†The table refers to the monthly cost of each drug, disregarding the duration of the therapy.